At its Q3 2026 earnings call, Xiangyu Medical announced that its rehabilitation robot business remains in the product registration and certification and clinical penetration stage. On the product front, the company has built out a portfolio spanning sports rehabilitation robots, AI physiotherapy robots, nursing and care robots, and traditional Chinese medicine acupuncture robots. Products including the AI infrared moxibustion robot and wearable lower-limb exoskeleton have been launched in succession, while multiple products in the AI physiotherapy robot series are undergoing medical device registration. On the market side, the related products have been deployed in hundreds of tertiary Grade A hospitals nationwide. The future scaling of this business will hinge on factors such as obtaining medical device registration certificates, the alignment of medical institution access and pricing policies, and the disbursement of funds under the rehabilitation and nursing capacity expansion program.